Online citations, reference lists, and bibliographies.
← Back to Search

The Genetic Susceptibility In The Development Of Malignant Pleural Mesothelioma.

O. Melaiu, F. Gemignani, S. Landi
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural mesothelioma (MPM) is a cancer of the pleural cavity whose main risk factor is exposure to asbestos. However, it has been shown that only a minority of exposed people develops MPM. In fact, the incidence among professionally exposed workers was shown to vary between 0.5% and 18.0%. Various hints suggested that other important cofactors could play a role, in particular the genetic susceptibility. Impressive is the case of Cappadocians families exposed to erionite and affected by an "epidemic" of MPM with about half of the inhabitants dying for the disease. However, no results for a "Cappadocia" gene of susceptibility to MPM have been obtained yet and more studies are needed. Among asbestos-exposed workers, several studies reported familial cases of MPM, suggesting that heredity could be important in the tumor development. However, large studies on familial clusters showed only weak increased risks that could be attributable also to indirect exposures in a contaminated household. Moreover, the risk of developing MPM is increased of a limited extent among people exposed to asbestos with a positive history of familial cancers. A particular is represented by carriers of germline mutations within BAP1 gene. In families and in animal models, mutations within BAP1 are strongly predisposing to develop MPM. However, also other types of cancer (such as uveal melanoma) are present, thus BAP1 mutations are considered as responsible for a hereditary form of a multi-cancer syndrome. In any case, among sporadic MPM, the prevalence of germline BAP1 mutations is negligible. Finally, genetic studies highlighted the presence of low-risk susceptibility alleles, such as those within XRCC3, NAT2 or GSTM1. Two different genome-wide association studies could not find positive associations reaching the genome-wide statistical significance threshold, however, both were concordant in showing a weak signal within the SDK1 gene region. Overall, it could be concluded that, as for other types of sporadic cancers, the susceptibility to develop MPM following asbestos exposure is modulated moderately by the individual genetic background. Further studies on larger series could help in a better characterization of more genes predisposing to MPM, being this tumor a rare disease.
This paper references
10.1002/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6
Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene
B. Deguen (1998)
10.3892/IJO.22.5.1009
Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
H. Schipper (2003)
10.1038/ng.912
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
10.1038/onc.2015.243
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
A. Napolitano (2016)
Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma.
A. Hirvonen (1995)
10.1371/journal.pone.0061253
Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study
G. Matullo (2013)
10.1016/S0304-3835(98)00142-6
Familial pleural malignant mesothelioma: clustering in three sisters and one cousin.
V. Ascoli (1998)
10.1073/PNAS.92.24.10854
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
A. Bianchi (1995)
p53 and Kirsten-ras mutations in human mesothelioma cell lines.
R. A. Metcalf (1992)
10.1183/09031936.99.13352399
Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort.
M. Metintas (1999)
10.1016/j.lungcan.2013.04.018
A genome-wide association study for malignant mesothelioma risk.
G. Cadby (2013)
10.1016/j.mrfmmm.2009.09.003
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
F. Gemignani (2009)
Manganese S252 Melaiu et al. Mesothelioma and genetic susceptibility © Journal of Thoracic Disease
VL Kinnula (2018)
10.1002/AJIM.20451
Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature.
V. Ascoli (2007)
10.1038/nrc2068
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
M. Carbone (2007)
10.1016/J.MRFMMM.2006.02.005
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
I. Dianzani (2006)
10.1002/ijc.27758
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
10.1016/j.canlet.2017.06.028
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
M. Betti (2017)
10.1111/j.1749-6632.1976.tb23127.x
HOUSEHOLD‐CONTACT ASBESTOS NEOPLASTIC RISK *
H. Anderson (1976)
10.1001/JAMA.1978.03290050057022
Familial mesothelioma after intense asbestos exposure at home.
F. Li (1978)
10.1002/dc.21859
Familial mesothelioma in first degree relatives
A. Kalogeraki (2013)
10.1016/0891-5849(96)00049-4
Manganese superoxide dismutase in human pleural mesothelioma cell lines.
V. Kinnula (1996)
10.1002/1097-0142(19800501)45:9<2422::AID-CNCR2820450930>3.0.CO;2-Z
Familial clustering of malignant mesothelioma
B. Risberg (1980)
10.1093/JNCI/88.24.1853
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
A. Hirvonen (1996)
10.1016/j.lungcan.2014.10.017
Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.
Andreas Rusch (2015)
10.1016/J.RMED.2006.06.028
Identification of a mesothelioma phenotype.
J. Ohar (2007)
10.1002/ijc.22590
Polymorphisms of glutathione‐S‐transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma
S. Landi (2007)
10.1016/j.mrfmmm.2011.01.001
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
M. Betti (2011)
10.1016/S0140-6736(00)04013-7
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
Iman Roushdy-Hammady (2001)
10.1016/0165-4608(93)90174-K
Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report.
I. Hansteen (1993)
Familial pleural malignant mesothelioma: clustering in three sisters and S251
V Ascoli (2018)
Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
T. Taguchi (1993)
10.1158/0008-5472.CAN-14-1328
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu (2014)
10.1016/j.gene.2015.03.031
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
Sophie Sneddon (2015)
10.1111/cge.12630
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases
K. Rai (2016)
10.1016/J.YRTPH.2007.10.003
Mesothelioma and asbestos.
G. Gibbs (2008)
10.2486/INDHEALTH.42.235
Familial mesothelioma of the pleura--a report of 40 cases.
C. Bianchi (2004)
10.1016/S0140-6736(78)90911-X
NON-OCCUPATIONAL EXPOSURE TO ASBESTOS AND MALIGNANT MESOTHELIOMA IN FEMALES
N. Vianna (1978)
10.1212/WNL.59.2.290
Neurofibromatosis 2 and malignant mesothelioma.
M. Baser (2002)
10.1158/0008-5472.CAN-05-4642
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey.
A. Dogan (2006)
10.1199/tab.0131
Glutathione Transferases
D. P. Dixon (2010)
10.1002/(SICI)1097-0142(19960201)77:3<549::AID-CNCR18>3.0.CO;2-4
Mesothelioma, asbestos, and reported history of cancer in first‐degree relatives
E. F. Heineman (1996)
10.1097/01.FPC.0000054067.64000.8F
The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria.
A. Sutton (2003)
10.1038/bjc.1985.108
Erionite exposure and mesotheliomas in rats.
J. Wagner (1985)
10.1002/gcc.22218
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area
M. Betti (2015)
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a highrisk area. Genes Chromosomes Cancer 2015;54:51-62
M Betti (2015)
10.21037/jtd.2017.10.41
The genetic susceptibility in the development of malignant pleural mesothelioma.
Ombretta Melaiu (2018)
10.1038/sj.onc.1206593
Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours
J. Fleury-Feith (2003)
10.1002/GCC.2870010207
Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes
W. Flejter (1989)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar